Evidence map›Paper›PMID 26269177›Full record

ArticleJournal of virology2015

Improvement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNA.

Anastasia Shunaeva, Daria Potashnikova, Alexey Pichugin, Alexandra Mishina, Alexander Filatov, Olga Nikolaitchik, Wei-Shau Hu, Dmitriy Mazurov

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Anastasia ShunaevaInstitute of Immunology, Moscow, Russia.
Daria PotashnikovaLomonosov Moscow State University, Moscow, Russia.
Alexey PichuginInstitute of Immunology, Moscow, Russia.
Alexandra MishinaInstitute of Immunology, Moscow, Russia.
Alexander FilatovInstitute of Immunology, Moscow, Russia.
Olga NikolaitchikHIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, Maryland, USA.
Wei-Shau HuHIV Dynamics and Replication Program, National Cancer Institute at Frederick, Frederick, Maryland, USA.
Dmitriy MazurovInstitute of Immunology, Moscow, Russia dvmazurov@yandex.ru.
Institute of Immunology and Physiology · RUFrederick National Laboratory for Cancer Research · USLomonosov Moscow State University · RUNational Cancer Institute · US

Funding

Understanding Retroviral Reverse Transcription, Recombination, and ReplicationZIABC010504 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HU, WEI-SHAU · 2009 to 2025
$5.3M
6 · The paper itself

Abstract

unlabelledCell-to-cell transmission is an efficient mechanism to disseminate human immunodeficiency virus type 1 (HIV-1) and human T cell lymphotropic virus type 1 (HTLV-1). However, it has been challenging to quantify the level of cell-to-cell transmission because the virus-producing cells cannot be easily distinguished from infected target cells. We have previously described replication-dependent vectors that can quantify infection events in cocultured cells. These vectors contain an antisense-oriented promoter and reporter gene interrupted by a sense-oriented intron from the human gamma-globin gene. This strategy prevents expression of the reporter gene in the transfected cells but permits its expression in target cells after infection. However, the gamma-globin intron is not efficiently removed by splicing in the aforementioned vectors, thereby reducing the level of reporter gene expression after transduction into target cells. Here, we used two approaches to improve the replication-dependent vectors. First, we improved the splicing events that remove the gamma-globin intron by optimizing the intron insertion site within the reporter gene. Second, we improved the packaging of the spliced RNA without the gamma-globin intron by targeting the intron-containing RNA via microRNA 30 (miR30)-based short hairpin RNAs. Using two optimized fluorescent reporter vectors and flow cytometry, we determined that multiply HIV-1-infected cells were generated at a higher frequency in coculture than in cell-free infection; furthermore, this increase was dependent upon viruses bearing HIV-1 Env. Compared with previously described vectors, these improved vectors can quantify the infection in lymphocytes and in primary cells with a higher sensitivity and allow the detection and quantitation of multiply infected cells, providing better tools to study retroviral cell-mediated infection. IMPORTANCE: The human-pathogenic retroviruses HTLV-1 and HIV-1 can be transmitted more efficiently in vivo via direct contact of infected cells with healthy target cells than through cell-free virion-mediated infection. Despite its importance, cell-to-cell transmission has been difficult to quantify because the previously infected cells and the newly infected cells are mixed together in the same culture. In the current study, we generated vectors that are significantly improved over the previously described replication-dependent vectors. As a result, these improved vectors can efficiently detect and quantify cell-to-cell transmission or new infection events in cells in mixed culture. These luciferase- or fluorescence protein-based reporter vectors can be used to quantify and study HIV-1 or HTLV-1 cell-mediated infection in a simple one-step transfection/infection assay.

Indexed as

Genes, ReporterBiological AssayCD4-Positive T-LymphocytesCell Linegamma-GlobinsGenetic EngineeringGenetic VectorsGreen Fluorescent ProteinsHEK293 CellsHIV-1HumansHuman T-lymphotropic virus 1IntronsLuciferasesLuminescent ProteinsMicroRNAsgamma-GlobinsGreen Fluorescent ProteinsLuciferasesLuminescent ProteinsMicroRNAsMIRN30b microRNA, humanRed Fluorescent ProteinRNA, Small Interfering

Identifiers

PMID26269177
PMCPMC4580202
OpenAlexW2212396457

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.